首页> 外文期刊>Virus Genes >Enhanced immunogenicity to food-and-mouth disease virus in mice vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1)
【24h】

Enhanced immunogenicity to food-and-mouth disease virus in mice vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1)

机译:用表达衣壳前体多肽(P1)的基于甲病毒的复制子为基础的DNA疫苗接种的疫苗对口蹄疫病毒的免疫原性增强

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, alphavirus replicon-based DNA vaccines, also known as suicidal DNA vaccines, have emerged as an important strategy to enhance the potency of DNA vaccines. In this study, two different types of DNA vaccines encoding the capsid precursor polypeptide (P1) of foot-and-mouth disease virus (FMDV) were constructed and the immunogenicity were investigated and compared in mouse model. The first DNA vaccine, pcDP1, is a conventional plasmid DNA vaccine in which P1 was driven directly by a cytomegalovirus promoter. The second DNA vaccine, pSCAP1, is a Semliki Forest virus (SFV) replicon-based DNA vaccine encoding the same antigen. In vitro expression and characterization indicated that two vaccine vectors could correctly produce the P1 antigen. However, pSCAP1 could induce obvious apoptosis of the transfected cells. After immunization in BALB/c mice, the P1-specific ELISA antibodies, neutralizing antibodies, as well as lymphocyte proliferative responses induced by pSCAP1 were significantly higher than those obtained in mice immunized with pcDP1. Notably, mice immunized with the pSCAP1 had the determined ability of clearing virus in their sera after FMDV challenge. These results indicate that the SFV replicon-based DNA vaccine pSCAP1 are more effective than conventional DNA vaccine and it can be considered a promising approach for the development of a safety and efficacious vaccine against FMDV.
机译:近来,基于甲病毒复制子的DNA疫苗,也被称为自杀DNA疫苗,已经成为增强DNA疫苗效力的重要策略。在这项研究中,构建了两种不同类型的编码口蹄疫病毒(FMDV)衣壳前体多肽(P1)的DNA疫苗,并在小鼠模型中研究了其免疫原性。第一种DNA疫苗pcDP1是常规的质粒DNA疫苗,其中P1由巨细胞病毒启动子直接驱动。第二种DNA疫苗pSCAP1是基于Semliki Forest病毒(SFV)复制子的DNA疫苗,编码相同的抗原。体外表达和表征表明两种疫苗载体可以正确产生P1抗原。但是,pSCAP1可以诱导转染细胞明显凋亡。在BALB / c小鼠中免疫后,pSCAP1诱导的P1特异性ELISA抗体,中和抗体以及淋巴细胞增殖反应显着高于用pcDP1免疫的小鼠。值得注意的是,在FMDV攻击后,用pSCAP1免疫的小鼠具有清除血清中病毒的确定能力。这些结果表明,基于SFV复制子的DNA疫苗pSCAP1比常规DNA疫苗更有效,可以认为它是开发针对FMDV的安全有效疫苗的有前途的方法。

著录项

  • 来源
    《Virus Genes》 |2006年第3期|337-344|共8页
  • 作者单位

    Laboratory of Animal Virology College of Veterinary Medicine Huazhong Agricultural University Wuhan 430070 Hubei P.R. China;

    Laboratory of Animal Virology College of Veterinary Medicine Huazhong Agricultural University Wuhan 430070 Hubei P.R. China;

    Laboratory of Animal Virology College of Veterinary Medicine Huazhong Agricultural University Wuhan 430070 Hubei P.R. China;

    Laboratory of Animal Virology College of Veterinary Medicine Huazhong Agricultural University Wuhan 430070 Hubei P.R. China;

    Laboratory of Animal Virology College of Veterinary Medicine Huazhong Agricultural University Wuhan 430070 Hubei P.R. China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Suicidal DNA vaccine; Foot-and-mouth disease Virus (FMDV); Capsid precursor polypeptide (P1); Immunogenicity;

    机译:自杀性DNA疫苗;口蹄疫病毒(FMDV);衣壳前体多肽(P1);免疫原性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号